Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line-6

Abstract

<p><b>Copyright information:</b></p><p>Taken from "Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line"</p><p>http://www.biomedcentral.com/1471-2407/7/216</p><p>BMC Cancer 2007;7():216-216.</p><p>Published online 20 Nov 2007</p><p>PMCID:PMC2233635.</p><p></p>brane and cytosolic fractions were isolated as described in Materials and Methods and then subjected to SDS-PAGE and Western blot analysis. The result of one representative assay from two similar independent experiments is shown. (B) Effect of TGZ on the distribution of PTEN. ES-2 cells were plated on FN (10 μg/mL)-coated coverslips and incubated in 10% FBS medium with 0.1% DMSO or 20 μM TGZ for 24 h. Cells were then double stained with paxillin (FITC) and PTEN (rhodamine). These results are representative of triplicate experiments

    Similar works

    Full text

    thumbnail-image

    Available Versions